Welcome to LookChem.com Sign In|Join Free

CAS

  • or

103983-87-5

Post Buying Request

103983-87-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

103983-87-5 Usage

Physical form

Yellow powder

Uses

Intermediate in the synthesis of pharmaceuticals and agricultural chemicals, reagent in various chemical reactions, production of dyes and pigments

Potential applications

Treatment of various diseases

Value in organic chemistry

Valuable compound due to its properties

Check Digit Verification of cas no

The CAS Registry Mumber 103983-87-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,9,8 and 3 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 103983-87:
(8*1)+(7*0)+(6*3)+(5*9)+(4*8)+(3*3)+(2*8)+(1*7)=135
135 % 10 = 5
So 103983-87-5 is a valid CAS Registry Number.

103983-87-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(p-Nitrophenyl)-2-thiopyridon

1.2 Other means of identification

Product number -
Other names 1-nitro-4-(2-thiopyridon-1-yl)benzene

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:103983-87-5 SDS

103983-87-5Relevant articles and documents

TETRAHYDROISOQUINOLINES AS FACTOR XA INHIBITORS

-

Page/Page column 62, (2008/06/13)

The present invention is directed to compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 103983-87-5